MS Research Australia is proud to have won the highest award on offer at the prestigious 2017 Telstra Business Awards: the Telstra NSW Business of the Year award. The organisation, which has made history as the first non-profit to receive this top award, was also named NSW Charity of the Year.
The Telstra Business Awards showcase the achievements and entrepreneurial spirit of Australia’s best small and medium businesses and, more recently, charities.
Announced in Sydney at the 25th annual Telstra New South Wales Business Awards, MS Research Australia was formally recognised for its innovation, global collaboration, and commitment to finding a cure for MS.
This award recognises MS Research Australia as a leader in the internationally coordinated effort to find a cure, as well as celebrating the success of its global fundraising campaign, Kiss Goodbye to MS. The Telstra Business Award judges were particularly impressed by the progressive approach to digital technologies taken by MS Research Australia, and the incredible research progress that has been made over the last 14 years.
Telstra Group Executive, Consumer and Small Business, and Awards Ambassador, Kevin Russell, said:
“MS Research Australia is the definition of innovation, leading the global charge against MS with its pioneering research methods. They’re a great example of an organisation using digital technology to remain at the forefront of the MS conversation and associated medical developments.”
Finding a cure
MS Research Australia’s Chief Executive Officer, Dr Matthew Miles, says the organisation’s efforts will only intensify as the global MS movement comes ever closer to eradicating the disease.
“Until we find a cure – and we’ve made incredible progress towards that – we will devote our attention to ensuring we are completely aligned with the needs of people with MS. We are at a tipping point and the finish line could potentially be in sight.”
MS Research Australia’s Head of Research, Dr Lisa Melton, who accepted the Award on behalf of the team, described it as a “great honour”.
She added: “It is a testament to all the people with MS and all of the supporters who have put their faith in us over the last 13 years and entrusted us with their funds and their hope – to accelerate research, to accelerate solutions, to bring treatments forward and bring us step by step closer to a cure for MS”.
Read the full article (external website opens in a new window)